fda bpc 157 category 2 compounding list BPC-157 Approval Status 2026: Clinical Trials The FDA's Category 2 list
The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law BPC 157 Legal Status: FDA Regulations and Compounding FDA Peptide Update: Category 2 Removals Explained
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


